e-learning
resources
European Respiratory Review
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Coinfection with
Pseudomonas aeruginosa
and
Aspergillus fumigatus
in cystic fibrosis
Karen Keown, Alastair Reid, John E. Moore, Clifford C. Taggart, Damian G. Downey
Source:
Eur Respir Rev, 29 (158) 200011; 10.1183/16000617.0011-2020
Journal Issue:
December
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Karen Keown, Alastair Reid, John E. Moore, Clifford C. Taggart, Damian G. Downey. Coinfection with
Pseudomonas aeruginosa
and
Aspergillus fumigatus
in cystic fibrosis. Eur Respir Rev, 29 (158) 200011; 10.1183/16000617.0011-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
IL-10 induced T-cell tolerance to
Aspergillus fumigatus
and
Pseudomonas aeruginosa
in cystic fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 8s
Year: 2001
Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis
Source: Eur Respir J 2005; 26: 651-656
Year: 2005
Eradication of Pseudomonas aeruginosa in cystic fibrosis
Source: Eur Respir J 2006; 27: 438-439
Year: 2006
Case-control study of Stenotrophomonas maltophilia acquisition in cystic fibrosis patients
Source: Eur Respir J 2004; 23: 98-102
Year: 2004
Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021
Eradication of Pseudomonas aeruginosa in cystic fibrosis patients
Source: Eur Respir J 2006; 27: 653
Year: 2006
Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa
Source: Eur Respir J 2003; 22: 503-506
Year: 2003
Impact of Aspergillus fumigatus infection on lung function in children with cystic fibrosis
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021
Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis
Source: Eur Respir J 2007; 30: 286-292
Year: 2007
Transmission-frequency of Aspergillus fumigatus in cystic fibrosis patients through coughing
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018
In vivo
evidence for aspergillus fumigatus and pseudomonas aeruginosa driven th-17 type inflammatory responses in the lungs of CF-patients
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009
Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients
Source: Eur Respir J 2008; 31: 822-829
Year: 2008
Parasexual recombination enables
Aspergillus fumigatus
to persist in cystic fibrosis
Source: ERJ Open Res, 6 (4) 00020-2020; 10.1183/23120541.00020-2020
Year: 2020
Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre
Source: Eur Respir J 2005; 25: 474-481
Year: 2005
Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018
Antibodies against Pseudomonas aeruginosa in patients with cystic fibrosis – clinical application
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018
Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre
Source: Eur Respir J 2006; 27: 937-943
Year: 2006
Interleukin-10 genotypes and airways colonization by
Aspergillus fumigatus
in cystic fibrosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 403s
Year: 2005
Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis
Source: Eur Respir J 2004; 24 : 631-637
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept